↓ Skip to main content

PLOS

Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

Mentioned by

policy
3 policy sources
twitter
8 X users
facebook
1 Facebook page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
70 Mendeley
Title
Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0051022
Pubmed ID
Authors

Tim K. Mackey, Bryan A. Liang

Abstract

The threat of non-communicable diseases ("NCDs") is increasingly becoming a global health crisis and are pervasive in high, middle, and low-income populations resulting in an estimated 36 million deaths per year. There is a need to assess intellectual property rights ("IPRs") that may impede generic production and availability and affordability to essential NCD medicines.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Cameroon 1 1%
United States 1 1%
India 1 1%
Unknown 67 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Student > Ph. D. Student 9 13%
Researcher 9 13%
Student > Master 9 13%
Student > Doctoral Student 7 10%
Other 15 21%
Unknown 11 16%
Readers by discipline Count As %
Medicine and Dentistry 23 33%
Pharmacology, Toxicology and Pharmaceutical Science 7 10%
Social Sciences 7 10%
Agricultural and Biological Sciences 4 6%
Business, Management and Accounting 3 4%
Other 13 19%
Unknown 13 19%